{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360565168923643136.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1186/1471-2369-12-64"}},{"identifier":{"@type":"URI","@value":"http://link.springer.com/content/pdf/10.1186/1471-2369-12-64.pdf"}},{"identifier":{"@type":"URI","@value":"http://link.springer.com/article/10.1186/1471-2369-12-64/fulltext.html"}},{"identifier":{"@type":"URI","@value":"http://link.springer.com/content/pdf/10.1186/1471-2369-12-64"}},{"identifier":{"@type":"URI","@value":"https://link.springer.com/content/pdf/10.1186/1471-2369-12-64.pdf"}},{"identifier":{"@type":"PMID","@value":"22111871"}}],"resourceType":"学術雑誌論文(journal article)","dc:title":[{"@value":"Excretion of complement proteins and its activation marker C5b-9 in IgA nephropathy in relation to renal function"}],"description":[{"type":"abstract","notation":[{"@value":"<jats:title>Abstract</jats:title>\n          <jats:sec>\n            <jats:title>Background</jats:title>\n            <jats:p>Glomerular damage in IgA nephropathy (IgAN) is mediated by complement activation via the alternative and lectin pathways. Therefore, we focused on molecules stabilizing and regulating the alternative pathway C3 convertase in urine which might be associated with IgAN pathogenesis.</jats:p>\n          </jats:sec>\n          <jats:sec>\n            <jats:title>Methods</jats:title>\n            <jats:p>Membrane attack complex (MAC), properdin (P), factor H (fH) and Complement receptor type 1 (CR1) were quantified in urine samples from 71 patients with IgAN and 72 healthy controls. Glomerular deposition of C5, fH and P was assessed using an immunofluorescence technique and correlated with histological severity of IgAN and clinical parameters. Fibrotic changes and glomerular sclerosis were evaluated in renal biopsy specimens.</jats:p>\n          </jats:sec>\n          <jats:sec>\n            <jats:title>Results</jats:title>\n            <jats:p>Immunofluorescence studies revealed glomerular depositions of C5, fH and P in patients with IgAN. Urinary MAC, fH and P levels in IgAN patients were significantly higher than those in healthy controls (p < 0.001), but CR1 was significantly lower than that in healthy controls (p < 0.001). Urinary MAC and fH levels were positively correlated with serum creatinine (sCr), urinary N-acetyl-β-D-glucosaminidase (u-NAG), urinary β2 microglobulin (u-Bm), urinary protein (p < 0.001), interstitial fibrosis (MAC: p < 0.01, fH: p < 0.05) and the percentage of global glomerular sclerosis (p < 0.01). Urinary P was positively correlated with u-NAG, u-Bm, and urinary protein (p < 0.01).</jats:p>\n          </jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions</jats:title>\n            <jats:p>Complement activation occurs in the urinary space in IgAN and the measurement of levels of MAC and fH in the urine could be a useful indicator of renal injury in patients with IgAN.</jats:p>\n          </jats:sec>"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1420845751164141568","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"60465044"},{"@type":"NRID","@value":"1000060465044"},{"@type":"NRID","@value":"9000273031444"},{"@type":"NRID","@value":"9000006042935"}],"foaf:name":[{"@value":"Kisara Onda"}]},{"@id":"https://cir.nii.ac.jp/crid/1380003447252872454","@type":"Researcher","foaf:name":[{"@value":"Isao Ohsawa"}]},{"@id":"https://cir.nii.ac.jp/crid/1380003447252872455","@type":"Researcher","foaf:name":[{"@value":"Hiroyuki Ohi"}]},{"@id":"https://cir.nii.ac.jp/crid/1380003447252872449","@type":"Researcher","foaf:name":[{"@value":"Mariko Tamano"}]},{"@id":"https://cir.nii.ac.jp/crid/1380003447252872453","@type":"Researcher","foaf:name":[{"@value":"Satoshi Mano"}]},{"@id":"https://cir.nii.ac.jp/crid/1380003447252872451","@type":"Researcher","foaf:name":[{"@value":"Michiro Wakabayashi"}]},{"@id":"https://cir.nii.ac.jp/crid/1380003447252872456","@type":"Researcher","foaf:name":[{"@value":"Akie Toki"}]},{"@id":"https://cir.nii.ac.jp/crid/1380003447252872457","@type":"Researcher","foaf:name":[{"@value":"Satoshi Horikoshi"}]},{"@id":"https://cir.nii.ac.jp/crid/1380003447252872450","@type":"Researcher","foaf:name":[{"@value":"Teizo Fujita"}]},{"@id":"https://cir.nii.ac.jp/crid/1380003447252872448","@type":"Researcher","foaf:name":[{"@value":"Yasuhiko Tomino"}]}],"publication":{"publicationIdentifier":[{"@type":"EISSN","@value":"14712369"}],"prism:publicationName":[{"@value":"BMC Nephrology"}],"dc:publisher":[{"@value":"Springer Science and Business Media LLC"}],"prism:publicationDate":"2011-11-23","prism:volume":"12","prism:number":"1","prism:startingPage":"64"},"reviewed":"false","dcterms:accessRights":"http://purl.org/coar/access_right/c_abf2","dc:rights":["http://www.springer.com/tdm"],"url":[{"@id":"http://link.springer.com/content/pdf/10.1186/1471-2369-12-64.pdf"},{"@id":"http://link.springer.com/article/10.1186/1471-2369-12-64/fulltext.html"},{"@id":"http://link.springer.com/content/pdf/10.1186/1471-2369-12-64"},{"@id":"https://link.springer.com/content/pdf/10.1186/1471-2369-12-64.pdf"}],"createdAt":"2011-11-23","modifiedAt":"2021-09-01","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=Adult","dc:title":"Adult"},{"@id":"https://cir.nii.ac.jp/all?q=Male","dc:title":"Male"},{"@id":"https://cir.nii.ac.jp/all?q=Adolescent","dc:title":"Adolescent"},{"@id":"https://cir.nii.ac.jp/all?q=Complement%20Pathway,%20Alternative","dc:title":"Complement Pathway, Alternative"},{"@id":"https://cir.nii.ac.jp/all?q=Kidney%20Glomerulus","dc:title":"Kidney Glomerulus"},{"@id":"https://cir.nii.ac.jp/all?q=Complement%20Membrane%20Attack%20Complex","dc:title":"Complement Membrane Attack Complex"},{"@id":"https://cir.nii.ac.jp/all?q=Kidney","dc:title":"Kidney"},{"@id":"https://cir.nii.ac.jp/all?q=Young%20Adult","dc:title":"Young Adult"},{"@id":"https://cir.nii.ac.jp/all?q=Humans","dc:title":"Humans"},{"@id":"https://cir.nii.ac.jp/all?q=Complement%20Activation","dc:title":"Complement Activation"},{"@id":"https://cir.nii.ac.jp/all?q=Aged","dc:title":"Aged"},{"@id":"https://cir.nii.ac.jp/all?q=Properdin","dc:title":"Properdin"},{"@id":"https://cir.nii.ac.jp/all?q=Glomerulonephritis,%20IGA","dc:title":"Glomerulonephritis, IGA"},{"@id":"https://cir.nii.ac.jp/all?q=Complement%20System%20Proteins","dc:title":"Complement System Proteins"},{"@id":"https://cir.nii.ac.jp/all?q=Middle%20Aged","dc:title":"Middle Aged"},{"@id":"https://cir.nii.ac.jp/all?q=Fibrosis","dc:title":"Fibrosis"},{"@id":"https://cir.nii.ac.jp/all?q=Diseases%20of%20the%20genitourinary%20system.%20Urology","dc:title":"Diseases of the genitourinary system. Urology"},{"@id":"https://cir.nii.ac.jp/all?q=Receptors,%20Complement","dc:title":"Receptors, Complement"},{"@id":"https://cir.nii.ac.jp/all?q=Nephrology","dc:title":"Nephrology"},{"@id":"https://cir.nii.ac.jp/all?q=Complement%20Factor%20H","dc:title":"Complement Factor H"},{"@id":"https://cir.nii.ac.jp/all?q=Female","dc:title":"Female"},{"@id":"https://cir.nii.ac.jp/all?q=RC870-923","dc:title":"RC870-923"},{"@id":"https://cir.nii.ac.jp/all?q=Biomarkers","dc:title":"Biomarkers"},{"@id":"https://cir.nii.ac.jp/all?q=Research%20Article","dc:title":"Research Article"}],"project":[{"@id":"https://cir.nii.ac.jp/crid/1040000782072905728","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"21390086"},{"@type":"JGN","@value":"JP21390086"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-21390086/"}],"notation":[{"@language":"ja","@value":"補体レクチン経路は第二経路の活性化に関与する"},{"@language":"en","@value":"The lectin complement pathway is involved in activation of the alternative pathway"}]},{"@id":"https://cir.nii.ac.jp/crid/1040282257144361472","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"23591482"},{"@type":"JGN","@value":"JP23591482"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-23591482/"}],"notation":[{"@language":"ja","@value":"補体制御因子の糖化より検討した被嚢性腹膜硬化症の病態解明と治療戦略"},{"@language":"en","@value":"Pathogenesis of encapsulating peritoneal sclerosis in the role of complement regulatory proteins and glycation"}]}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360004236782328064","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Properdin has an ascendancy over factor H regulation in complement-mediated renal tubular damage"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283694403185280","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Dual Involvement of Growth Arrest-Specific Gene 6 in the Early Phase of Human IgA Nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617436174208","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Complement activation is associated with crescent formation in IgA nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574095802658944","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"No complement receptor 1 stumps on podocytes in human glomerulopathies"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137044168100096","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Urinary Complement Factor H in Renal Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418518734969344","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Membrane complement regulatory proteins: insight from animal studies and relevance to human diseases"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418519183588736","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"IgA Nephropathy: Clinicopathology and Immunopathology"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418520342144512","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Levels of Urinary Complement Factor H in Patients with IgA Nephropathy are Closely Associated with Disease Activity"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418520344857216","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Glomerular Deposition and Urinary Excretion of Complement Factor H in Idiopathic Membranous Nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699995597177088","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Quantitative polymorphism of complement receptor type 1 (CR1) in patients undergoing haemodialysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981468915859200","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Hypercomplementemia in adult patients with IgA nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981471288404224","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Control of the amplification convertase of complement by the plasma protein beta1H."}]},{"@id":"https://cir.nii.ac.jp/crid/1362262945236302336","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Regulation of C3 and factor H synthesis of human glomerular mesangial cells by IL-1 and interferon-gamma"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262946061892864","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Measurement of SC5b-9 in urine in patients with the nephrotic syndrome"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544418597635840","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Complement Factor H as a Marker for Detection of Bladder Cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544419027378560","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Complement-Mediated Dysfunction of Glomerular Filtration Barrier Accelerates Progressive Renal Injury"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544419175282176","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Modulation of C3b Hemolytic Activity by a Plasma Protein Distinct from C3b Inactivator"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544420567688064","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase."}]},{"@id":"https://cir.nii.ac.jp/crid/1362825895972139904","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins."}]},{"@id":"https://cir.nii.ac.jp/crid/1363107369188582400","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Identification of membrane-bound CR1 (CD35) in human urine: evidence for its release by glomerular podocytes."}]},{"@id":"https://cir.nii.ac.jp/crid/1363388844781986560","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution."}]},{"@id":"https://cir.nii.ac.jp/crid/1363388845258991616","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Cellular Response to Injury in Membranous Nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670320155698944","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"INTERFERON-γ INDUCES BIOSYNTHESIS OF COMPLEMENT COMPONENTS C2, C4 AND FACTOR H BY HUMAN PROXIMAL TUBULAR EPITHELIAL CELLS"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951793379660800","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233268200059264","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Abnormal expression of complement receptor (CR1) in IgA nephritis: Increase in erythrocytes and loss on glomeruli in patients with impaired renal function"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233269786371968","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Glomerular Activation of the Lectin Pathway of Complement in IgA Nephropathy Is Associated with More Severe Renal Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233270478147840","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Human IgA Activates the Complement System Via the Mannan-Binding Lectin Pathway"}]},{"@id":"https://cir.nii.ac.jp/crid/2051151842048569216","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Clinical guidelines for immunoglobulin A (IgA) nephropathy in Japan, second version"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1186/1471-2369-12-64"},{"@type":"KAKEN","@value":"PRODUCT-12711345"},{"@type":"KAKEN","@value":"PRODUCT-14164637"},{"@type":"OPENAIRE","@value":"doi_dedup___::1a79ac3cd479f47e8c30bfff31e3bdae"},{"@type":"CROSSREF","@value":"10.1186/1471-2369-15-82_references_DOI_Sx2O8NeXXHSsJquXiLl9iIAxXVv"},{"@type":"CROSSREF","@value":"10.1371/journal.pone.0066759_references_DOI_Sx2O8NeXXHSsJquXiLl9iIAxXVv"},{"@type":"CROSSREF","@value":"10.1007/s00428-020-02800-0_references_DOI_Sx2O8NeXXHSsJquXiLl9iIAxXVv"}]}